Related Experiment Videos
Gene therapy for prostate cancer
Yehoshua Gdor1, Terry L Timme, Brian J Miles
1Scott Department of Urology, Baylor College of Medicine, 6560 Fannin, Suite 2100, Houston, TX 77030, USA.
Abstract:
Prostate cancer is the most common noncutaneous cancer in man. When confined to the prostate it can be cured by radical prostatectomy or irradiation therapy. However, there are no curative therapies for locally advanced, recurrent or metastatic disease. Prostate cancer gene therapy has recently transition from preclinical studies to clinical trials with the goal of developing novel treatments for prostate cancer. The greatest challenge in treating advanced prostate cancer is therapeutic access to and the elimination of metastases. This review details two aspects of prostate cancer gene therapy, the types of delivery systems under development and specific categories of therapeutic genes available with an emphasis on the mechanism of action of specific gene therapy strategies.
Insights
Prostate cancer gene therapy is emerging as a novel treatment for advanced disease. This review covers gene delivery systems and therapeutic genes for improved prostate cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Prostate cancer is a leading noncutaneous cancer in men.
- Current treatments fail for locally advanced, recurrent, or metastatic prostate cancer.
- Gene therapy offers a promising avenue for novel prostate cancer treatments.
Purpose of the Study:
- To review current prostate cancer gene therapy strategies.
- To detail delivery systems and therapeutic genes for advanced prostate cancer.
- To emphasize the mechanisms of action for gene therapy approaches.
Main Methods:
- Review of preclinical and clinical studies on prostate cancer gene therapy.
- Analysis of gene delivery systems under development.
- Categorization of available therapeutic genes and their mechanisms.
Main Results:
- Gene therapy is transitioning from preclinical to clinical trials for prostate cancer.
- Delivery systems and therapeutic genes are key components of gene therapy strategies.
- Understanding gene therapy mechanisms is crucial for treating metastatic disease.
Conclusions:
- Prostate cancer gene therapy holds potential for treating advanced and metastatic disease.
- Development of effective delivery systems and therapeutic genes is ongoing.
- Further research into gene therapy mechanisms can enhance treatment efficacy.